Top Consumer Driven Health Care Stories
Novo Nordisk files patent claims to fend off generic rivals
By Alexa WoronowiczSun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular weight-loss drug. Novo Nordisk says the efforts infringe on its patent.









